Peer-generated best practices, guidance documents, and session highlights
Is your biotech product launch destined for success? You gotta figure out strategies for making a big impact in the industry. It’s a daunting task,
The stakes have never been higher for biotech, pharma, and medtech sales organizations. We explore ways that medical affairs, sales, and all customer-facing professionals can exceed the expectations of their customers and companies.
Delivering and Delighting HCP’s Everyone in the biopharmaceutical and MedTech space knows that customer-facing teammates need to win the attention of the health care professionals
Human capital is the most valuable resource for life science organizations. However, ever-changing workforce requirements can be challenging, which the pharma industry can overcome by outsourcing services.
Besides the pressure to maintain lower healthcare costs and increased competition from new entrants, life science companies find it challenging to market themselves and expand their reach.
Getting on the formulary is more difficult than ever before, given the number of new, high-cost drugs that are entering the market. That’s one of the reasons why Frank Dolan sat down with Steve O’Malley, Executive Vice President of Market Access at Two Labs, as part of the Life Science Leader Lab series.
The life sciences field is very complicated, but before you can get your product in the hands of patients who need them, you first need to get approved by payers.
The traditional methods of generating revenue in pharmaceutical markets are no longer effective. To deliver positive results for their businesses, the healthcare industry must consider patient loyalty as part of their marketing strategy.
Here are eight strategies to boost virtual sales in the healthcare industry during these unprecedented times:
Catching up with Tamar Frank Dolan, CEO of ARSENAL ADVISORS, caught up with Tamar Thompson, Vice President of Government Affairs at Alexion Pharmaceuticals, at the
Mastering the Art of Virtual Sales Calls for BioPharma & MedTech The Covid-19 pandemic has changed how we live, and especially how we work. With
4 Myths About the Biopharma Industry Many myths and conspiracy theories surround the pharma sector, from exaggerating production costs to giving the public sector credit
Life science conferences and summits provide a unique platform to share ideas and emerging knowledge with the larger medical research community. Most biotech and pharma
ARSENAL Life Science is a division of ARSENAL ADVISORS, LLC.
Empowering life science industry leaders with exclusive content, networking, and data-driven decision making tools.
